MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 1 analysts with an average price target of $30.75. This is a potential upside of $1.67 (5.74%) from yesterday's end of day stock price of $29.08.

Mersana Therapeutics's activity chart (see below) currently has 53 price targets and 58 ratings on display. The stock rating distribution of MRSN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.36% with an average time for these price targets to be met of 337.06 days.

Highest price target for MRSN is $30.75, Lowest price target is $30.75, average price target is $30.75.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 13-Nov-2025. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Aug-2025

$30.75

$1.67 (5.74%)

$36

10 months 17 days ago
(13-Nov-2025)

0/2 (0%)

$3.32 (12.10%)

Buy Since 13-Aug-2025

$17

10 months 17 days ago
(13-Nov-2025)

1/1 (100%)

$10.19 (149.63%)

92

Buy Since 16-May-2025

$30

$0.92 (3.16%)

1 years 1 months 16 days ago
(14-Aug-2025)

1/3 (33.33%)

$22.58 (304.31%)

1072

Buy Since 06-May-2025

$175

1 years 4 months 24 days ago
(06-May-2025)

5/8 (62.5%)

$39 (28.68%)

550

Buy Since 27-Aug-2024

$125

2 years 1 months 3 days ago
(27-Aug-2024)

1/2 (50%)

$74 (145.10%)

87

Show more analysts

Please expand the browser size to see the chart

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 337 days for the stock forecasts to be reached, with an average price target met ratio of 47.36%.

Which analyst most recently updated their price target on MRSN (Mersana Therapeutics)?

Asthika Goonewardene

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Asthika Goonewardene works at TRUIST and has 18 price targets and 17 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Jonathan Chang with the highest potential upside of $8095.92

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Thomas Shrader with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?